Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase score

BACKGROUND AND AIM: This retrospective study investigated the effect of 48‐week pemafibrate therapy in non‐alcoholic fatty liver disease (NAFLD) with hypertriglyceridemia, as evaluated by the FibroScan‐aspartate aminotransferase (FAST) score. METHODS: A total of 31 NAFLD patients who were treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatanaka, Takeshi, Kosone, Takashi, Saito, Naoto, Takakusagi, Satoshi, Tojima, Hiroki, Naganuma, Atsushi, Takagi, Hitoshi, Uraoka, Toshio, Kakizaki, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485409/
https://www.ncbi.nlm.nih.gov/pubmed/34622006
http://dx.doi.org/10.1002/jgh3.12650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485409/
https://www.ncbi.nlm.nih.gov/pubmed/34622006
http://dx.doi.org/10.1002/jgh3.12650

Ejemplares similares